To read this content please select one of the options below:

Prevalence of COVID-19 in prison population: a meta-analysis of 35 studies

SeyedAhmad SeyedAlinaghi (Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran)
Soudabeh Yarmohammadi (Kashan University of Medical Sciences, Kashan, Iran)
Farid Farahani Rad (Tehran University of Medical Sciences, Tehran, Iran)
Muhammad Ali Rasheed (Tehran University of Medical Sciences, Tehran, Iran)
Mohammad Javaherian (Tehran University of Medical Sciences, Tehran, Iran)
Amir Masoud Afsahi (Department of Radiology, University of California, San Diego, CA, USA)
Haleh Siami (Islamic Azad University, Shahreza, Iran)
AmirBehzad Bagheri (Baylor College of Medicine, Houston, Texas, USA)
Ali Zand (Tehran University of Medical Sciences, Tehran, Iran)
Omid Dadras (Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran)
Esmaeil Mehraeen (Ardabil University of Medical Sciences, Ardabil, Iran and Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran)

International Journal of Prison Health

ISSN: 2977-0254

Article publication date: 17 September 2024

Issue publication date: 5 December 2024

30

Abstract

Purpose

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Considering the restricted and enclosed nature of prisons and closed environments and the prolonged and close contact between individuals, COVID-19 is more likely to have a higher incidence in these settings. This study aims to assess the prevalence of COVID-19 among prisoners.

Design/methodology/approach

Papers published in English from 2019 to July 7, 2023, were identified using relevant keywords such as prevalence, COVID-19 and prisoner in the following databases: PubMed/MEDLINE, Scopus and Google Scholar. For the meta-analysis of the prevalence, Cochrane’s Q statistics were calculated. A random effect model was used due to the heterogeneity in COVID-19 prevalence across included studies in the meta-analysis. All analyses were performed in STATA-13.

Findings

The pooled data presented a COVID-19 prevalence of 20% [95%CI: 0.13, 0.26] and 24% [95%CI: 0.07, 0.41], respectively, in studies that used PCR and antibody tests. Furthermore, two study designs, cross-sectional and cohort, were used. The results of the meta-analysis showed studies with cross-sectional and cohort designs reported 20% [95%CI: 0.11, 0.29] and 25% [95%CI: 0.13, 0.38], respectively.

Originality/value

Through more meticulous planning, it is feasible to reduce the number of individuals in prison cells, thereby preventing the further spread of COVID-19.

Keywords

Acknowledgements

The authors have no conflict of interest.

Citation

SeyedAlinaghi, S., Yarmohammadi, S., Farahani Rad, F., Rasheed, M.A., Javaherian, M., Afsahi, A.M., Siami, H., Bagheri, A., Zand, A., Dadras, O. and Mehraeen, E. (2024), "Prevalence of COVID-19 in prison population: a meta-analysis of 35 studies", International Journal of Prison Health, Vol. 20 No. 4, pp. 393-409. https://doi.org/10.1108/IJOPH-01-2024-0005

Publisher

:

Emerald Publishing Limited

Copyright © 2024, Emerald Publishing Limited

Related articles